Read More Healthcare Industry News Biolinq’s needle-free glucose monitor wins FDA nod — Could this disrupt Dexcom and Abbott’s CGM dominance? Biolinq Shine earns FDA de novo clearance as the first needle-free CGM, challenging Dexcom and Abbott in the diabetes tech market. byPallavi MadhirajuSeptember 27, 2025